跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
KADIAN morphine sulfate pentahydrate 100mg sustained release capsule bulk
Approved
STANDARD
KADIAN morphine sulfate pentahydrate 100mg sustained release capsule bulk
Mayne Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
6de6c4690c2670e6
Company
Mayne Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
6de6c4690c2670e6
Product Name
KADIAN morphine sulfate pentahydrate 100mg sustained release capsule bulk
Artg Id
55367
Artg Name
KADIAN morphine sulfate pentahydrate 100mg sustained release capsule bulk
Sponsor
Mayne Pharma International Pty Ltd
Company Detail Path
/organization/mayne-pharma-international-pty-ltd
Artg Date
1996-05-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
6de6c4690c2670e6
Type
Standard
Back to TGA Approvals
KADIAN morphine sulfate pentahydrate 100mg sustained release capsule bulk - TGA Drug Approval Details
